Pathogens 2016, 5(1), 24; doi:10.3390/pathogens5010024
Urinary Tract Infection Molecular Mechanisms and Clinical Translation
Gabriela Godaly *
, Ines Ambite, Manoj Puthia, Aftab Nadeem, James Ho, Karoly Nagy, Yujing Huang, Gustav Rydström and Catharina Svanborg
, Ines Ambite, Manoj Puthia, Aftab Nadeem, James Ho, Karoly Nagy, Yujing Huang, Gustav Rydström and Catharina SvanborgDepartment of Microbiology, Immunology and Glycobiology (MIG), Institute of Laboratory Medicine, Lund University, 221 00 Lund, Sweden
*
Author to whom correspondence should be addressed.
Academic Editor: Lawrence S. Young
Received: 12 November 2015 / Revised: 5 February 2016 / Accepted: 5 February 2016 / Published: 24 February 2016
(This article belongs to the Special Issue Molecular Aspects of Urinary Tract Infection)
Abstract
Rapid developments in infection biology create new and exciting options for individualized diagnostics and therapy. Such new practices are needed to improve patient survival and reduce morbidity. Molecular determinants of host resistance to infection are being characterized, making it possible to identify susceptible individuals and to predict their risk for future morbidity. Immunotherapy is emerging as a new strategy to treat infections worldwide and controlled boosting of the host immune defense represents an important therapeutic alternative to antibiotics. In proof of concept studies, we have demonstrated that this approach is feasible. The long-term goal is not just to remove the pathogens but to also develop technologies that restore resistance to infection in disease-prone patients and devise personalized therapeutic interventions. Here, we discuss some approaches to reaching these goals, in patients with urinary tract infection (UTI). We describe critical host signaling pathways that define symptoms and pathology and the genetic control of innate immune responses that balance protection against tissue damage. For some of these genes, human relevance has been documented in clinical studies, identifying them as potential targets for immune-modulatory therapies, as a complement to antibiotics. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Godaly, G.; Ambite, I.; Puthia, M.; Nadeem, A.; Ho, J.; Nagy, K.; Huang, Y.; Rydström, G.; Svanborg, C. Urinary Tract Infection Molecular Mechanisms and Clinical Translation. Pathogens 2016, 5, 24.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
Pathogens
EISSN 2076-0817
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert